Maintenance therapy with bevacizumab with or without erlotinib in metastatic colorectal cancer (mCRC) according to KRAS: Results of the GERCOR DREAM phase III trial.
暂无分享，去创建一个
C. Tournigand | W. Scheithauer | F. Bonnetain | F. Viret | J. Latreille | A. Gramont | T. André | C. Louvet | N. Tubiana-Mathieu | G. Lledo | B. Chibaudel | J. Dauba | A. Khalil | N. Aucoin | O. Dupuis | M. Mabro | B. Samson | Y. Rinaldi | J. Ramée | D. Brusquant